Unlocking stem cells’ full potential for treating multiple sclerosis
5 min readJan 28, 2022
Highs, lows and future opportunities from OHRI’s MESEMS trial
Article via Signals Blog
Cells that are programmed to protect can sometimes go rogue, as is the case with multiple sclerosis, or MS. Overactive immune cells mistakenly target the tissues of the brain, spinal cord and optic nerves, igniting inflammatory flare-ups…